biote Corp.
BTMD
$1.79
-$0.17-8.67%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -8.28% | -6.87% | -6.67% | -0.62% | 4.67% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -8.28% | -6.87% | -6.67% | -0.62% | 4.67% |
| Cost of Revenue | 10.88% | 5.67% | -11.39% | -9.67% | -6.26% |
| Gross Profit | -14.92% | -11.79% | -4.68% | 3.49% | 9.08% |
| SG&A Expenses | 1.99% | -6.72% | 10.99% | -10.86% | 17.02% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.89% | -2.69% | 2.10% | -10.43% | 8.25% |
| Operating Income | -57.50% | -34.16% | -32.77% | 62.94% | -6.82% |
| Income Before Tax | -80.88% | 559.26% | -46.70% | 159.01% | 625.12% |
| Income Tax Expenses | -59.03% | 163.49% | -123.92% | 2,845.21% | -32.72% |
| Earnings from Continuing Operations | -83.10% | -24.86% | -27.19% | 137.86% | 376.62% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 81.19% | -401.36% | 47.42% | -122.55% | -235.53% |
| Net Income | -83.40% | -47.23% | -23.49% | 144.94% | 429.68% |
| EBIT | -57.50% | -34.16% | -32.77% | 62.94% | -6.82% |
| EBITDA | -53.43% | -30.98% | -29.73% | 59.17% | -4.80% |
| EPS Basic | -82.95% | -46.20% | -24.19% | 146.99% | 462.48% |
| Normalized Basic EPS | -54.57% | -85.16% | -19.95% | -24.56% | -62.92% |
| EPS Diluted | -83.78% | -36.62% | -33.33% | 146.66% | 407.82% |
| Normalized Diluted EPS | -54.63% | -82.32% | -28.98% | -24.84% | -68.40% |
| Average Basic Shares Outstanding | -2.67% | -1.87% | 0.92% | -4.37% | -9.06% |
| Average Diluted Shares Outstanding | -2.59% | -17.33% | 13.79% | -4.02% | 6.74% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -0.98% | 1.85% | -- |